Ticker Details
Abbott Laboratories Abbott Laboratories is a health care company that manufactures medical devices, blood glucose monitoring kits, nutritional healthcare products, diagnostic products and equipment, and branded generic drugs.
IPO Date:	December 24, 1981
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$190.38B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.59 | 0.86%
Avg Daily Range (30 D):	$1.13 | 1.02%
Avg Daily Range (90 D):	$1.07 | 0.90%

Institutional Daily Volume
Avg Daily Volume:	5.66M
Avg Daily Volume (30 D):	8.94M
Avg Daily Volume (90 D):	6.5M

Trade Size
Avg Trade Size (Sh.):	144
Avg Trade Size (Sh.) (30 D):	75
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	100,713
Avg Institutional Trade:	$5.63M
Avg Institutional Trade (30 D):	$11.9M
Avg Institutional Trade (90 D):	$13.48M
Avg Institutional Trade Volume:	.08M
Avg Institutional Trades (Per Day):	17

Market Closing Trades
Avg Closing Trade:	$52.84M
Avg Closing Trade (30 D):	$164.75M
Avg Closing Trade (90 D):	$156.42M
Avg Closing Volume:	642.72K

News

Mar 10, 2026 @ 7:32 AM Molecular Diagnostics Market Outlook: Set to Grow ... Source: Mordor Intelligence

Mar 5, 2026 @ 9:45 AM Respiratory Disease Testing Market Global Forecast... Source: Researchandmarkets.Com

Mar 3, 2026 @ 9:00 AM Personalized Nutrition Market Size to Reach USD 60... Source: Sns Insider

Mar 2, 2026 @ 9:59 AM Antibiotics Market - 4.07% CAGR Forecast for 2026-... Source: Mordor Intelligence

Feb 26, 2026 @ 6:46 PM VivaVision Eyes Hong Kong Listing Before Cash Coff... Source: Bamboo Works

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$3.73		$3.73
Diluted EPS	$3.72		$3.72
Revenue	$44.33B		$44.33B
Gross Profit	$25.01B		$25.01B
Net Income / Loss	$6.52B		$6.52B
Operating Income / Loss	$8.05B		$8.05B
Cost of Revenue	$19.32B		$19.32B
Net Cash Flow	$835M		$835M
PE Ratio	0.00